RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Chong Kun Dang Pharmaceutical Corp
Chong Kun Dang Pharmaceutical Corporation
  

Chong Kun Dang Pharmaceutical Corp patents

Recent patent applications related to Chong Kun Dang Pharmaceutical Corp. Chong Kun Dang Pharmaceutical Corp is listed as an Agent/Assignee. Note: Chong Kun Dang Pharmaceutical Corp may have other listings under different names/spellings. We're not affiliated with Chong Kun Dang Pharmaceutical Corp, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Chong Kun Dang Pharmaceutical Corp-related inventors




Date Chong Kun Dang Pharmaceutical Corp patents (updated weekly) - BOOKMARK this page
08/27/15Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
06/01/17Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
05/11/17Amide derivatives for gpr119 agonist
04/06/17Novel compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
12/08/16Novel indole derivative compound and pharmaceutical composition comprising the same
10/06/16Novel azaindole derivatives as selective histone deacetylase (hdac) inhibitors and pharmaceutical compositions comprising the same
08/18/16Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as cetp inhibitors
03/24/16Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
01/21/16Animal model of charcot-marie-tooth disease as hsp27 mutant (s135f) carrier
01/14/16Screening therapeutic agents for charcot-marie-tooth disease and self-differentiation motor neurons used therefor
12/31/15Composition for gene delivery comprising chitosan and liquid crystal formation material
11/12/15Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as cetp inhibitors
10/22/15Sustained-release lipid pre-concentrate of gnrh analogues and pharmaceutical composition comprising the same
10/15/15Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same
09/24/15Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the same
09/10/15N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug
06/18/15Piperidine derivatives for gpr119 agonist
04/30/15Cycloalkenyl aryl derivatives for cetp inhibitor
04/23/15Novel composition for gene delivery
04/16/15Anti-erbb2 antibody variants
10/23/14Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
08/28/14Methods for purifying erythropoietin analogs having lower isoelectric point
07/24/14Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
04/03/14Expression vector for animal cells including csp-b 5'-sar factor and producing recombinant proteins using same
01/30/14Cycloalkenyl aryl derivatives for cetp inhibitor
02/02/12Novel hydroxamate derivative, a production the same, and a pharmaceutical composition comprising the same
01/27/11Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and producing the same
01/20/11Method for the preparation of atorvastatin and intermediates used therein
03/04/10Fumagillol derivatives or preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same
11/05/09Benzophenone derivatives useful for inhibiting formation of microtubule
02/05/09Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Chong Kun Dang Pharmaceutical Corp in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Chong Kun Dang Pharmaceutical Corp with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';